Biomolecules 2013, 3(3), 481-513; doi:10.3390/biom3030481
Review

The Impact of Sphingosine Kinase-1 in Head and Neck Cancer

1 Cancer Biology Program, University of Hawaii Cancer Center, 701 Ilalo Street, Honolulu, HI 96813, USA 2 Department of Molecular Biosciences and Bioengineering, University of Hawaii at Manoa, Honolulu, HI 96818, USA
* Author to whom correspondence should be addressed.
Received: 1 July 2013; in revised form: 2 August 2013 / Accepted: 3 August 2013 / Published: 12 August 2013
(This article belongs to the Special Issue Sphingolipids and Bioactive Lipids)
PDF Full-text Download PDF Full-Text [1033 KB, uploaded 12 August 2013 17:10 CEST]
Abstract: Head and neck squamous cell carcinoma (HNSCC) has a high reoccurrence rate and an extremely low survival rate. There is limited availability of effective therapies to reduce the rate of recurrence, resulting in high morbidity and mortality of advanced cases. Late presentation, delay in detection of lesions, and a high rate of metastasis make HNSCC a devastating disease. This review offers insight into the role of sphingosine kinase-1 (SphK1), a key enzyme in sphingolipid metabolism, in HNSCC. Sphingolipids not only play a structural role in cellular membranes, but also modulate cell signal transduction pathways to influence biological outcomes such as senescence, differentiation, apoptosis, migration, proliferation, and angiogenesis. SphK1 is a critical regulator of the delicate balance between proliferation and apoptosis. The highest expression of SphK1 is found in the advanced stage of disease, and there is a positive correlation between SphK1 expression and recurrent tumors. On the other hand, silencing SphK1 reduces HNSCC tumor growth and sensitizes tumors to radiation-induced death.  Thus, SphK1 plays an important and influential role in determining HNSCC proliferation and metastasis. We discuss roles of SphK1 and other sphingolipids in HNSCC development and therapeutic strategies against HNSCC.
Keywords: sphingolipids; SphK1; S1P; head and neck cancer; invasion and proliferation

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Tamashiro, P.M.; Furuya, H.; Shimizu, Y.; Iino, K.; Kawamori, T. The Impact of Sphingosine Kinase-1 in Head and Neck Cancer. Biomolecules 2013, 3, 481-513.

AMA Style

Tamashiro PM, Furuya H, Shimizu Y, Iino K, Kawamori T. The Impact of Sphingosine Kinase-1 in Head and Neck Cancer. Biomolecules. 2013; 3(3):481-513.

Chicago/Turabian Style

Tamashiro, Paulette M.; Furuya, Hideki; Shimizu, Yoshiko; Iino, Kayoko; Kawamori, Toshihiko. 2013. "The Impact of Sphingosine Kinase-1 in Head and Neck Cancer." Biomolecules 3, no. 3: 481-513.

Biomolecules EISSN 2218-273X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert